Cargando…
ApmA Is a Unique Aminoglycoside Antibiotic Acetyltransferase That Inactivates Apramycin
Apramycin is an aminoglycoside antibiotic with the potential to be developed to combat multidrug-resistant pathogens. Its unique structure evades the clinically widespread mechanisms of aminoglycoside resistance that currently compromise the efficacy of other members in this drug class. Of the amino...
Autores principales: | Bordeleau, Emily, Stogios, Peter J., Evdokimova, Elena, Koteva, Kalinka, Savchenko, Alexei, Wright, Gerard D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885111/ https://www.ncbi.nlm.nih.gov/pubmed/33563840 http://dx.doi.org/10.1128/mBio.02705-20 |
Ejemplares similares
-
The evolution of substrate discrimination in macrolide antibiotic resistance enzymes
por: Pawlowski, Andrew C., et al.
Publicado: (2018) -
Structural and Molecular Basis for Resistance to Aminoglycoside Antibiotics by the Adenylyltransferase ANT(2″)-Ia
por: Cox, Georgina, et al.
Publicado: (2015) -
Rifampin phosphotransferase is an unusual antibiotic resistance kinase
por: Stogios, Peter J., et al.
Publicado: (2016) -
Structural and molecular rationale for the diversification of resistance mediated by the Antibiotic_NAT family
por: Stogios, Peter J., et al.
Publicado: (2022) -
In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii
por: Juhas, Mario, et al.
Publicado: (2019)